Sage Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023
The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230201006095/en/
Contacts
Investor Contact
Helen Rubinstein
315-382-3979
helen.rubinstein@sagerx.com
Media Contact
Matthew Henson
917-930-7147
matthew.henson@sagerx.com
Source: Sage Therapeutics, Inc.